Vancouver, BC, February 7, 2019– Orion Nutraceuticals Inc., (CSE: ORI) (the “Company” or “Orion”) a cannabis life science company, is pleased to share the Cannabis MD report of February 4th, 2019 outlining the growing acceptance of CBD and Cannabis derived sports therapies in the United States. In conjunction with its professional sports strategic alliances, Orion Nutraceuticals is poised to advance research and development in the plant science sector, deliver science-based products and services, and market CBD therapies to the mainstream with proprietary brands and products.

2019 is shaping up to be another landmark year for cannabis in the United States. For starters, more farmers will be able to grow industrial hemp thanks to the 2018 Farm Bill. The plant is losing its stigma among public authorities like U.S. Surgeon General Jerome Adams, who floated the idea of removing cannabis from the list of Schedule I substances (meaning a drug that possesses no medicinal qualities and poses a high risk of abuse). Meanwhile, states like Texas and Virginia may vote to decriminalize cannabis, and there is a very good chance that at least nine states — Connecticut, Illinois, Minnesota, New Hampshire, New Jersey, New Mexico, New York, Rhode Island, and Vermont (where possession is currently legal, though commercial sales are not) — could pass legislation that will end the prohibition of recreational cannabis by the end of the year, which would make it legal in 18 states. It would also mean that 45 percent of American adults live in a place where recreational cannabis is legal.

2019 may also be the year in which professional sports leagues finally come to embrace cannabis, though not for recreational purposes. This is because one of the compounds found in cannabis, cannabidiol (CBD), could be a boon for athletes. A growing body of research suggests that CBD can be used to treat chronic pain, anxiety, and some sleep disorders — precisely the kinds of problems many athletes deal with. Furthermore, unlike tetrahydrocannabinol (THC), probably the most famous compound in cannabis, CBD has no psychoactive effects, meaning those who use it do not get “high.”

Though the therapeutic benefits of CBD have been studied for decades, products containing the compound were not readily available to the American public until relatively recently. Within the past two years, however, its popularity has exploded as its benefits have been discovered by people from all walks of life — including many athletes. For many, it was a welcome alternative to prescription drugs that can become addictive or cause unwanted side-effects. “A lot of guys get run down different roads, seeing different doctors and getting different treatments, and it’s making their condition worse,” said Riley Cote, a former enforcer for the Philadelphia Flyers. Since retiring in 2010, Cote has become one of the sports world’s most vocal proponents of cannabis. As co-founder of Athletes for Care, a not-for-profit dedicated to improving the lives of retired athletes, he has seen first-hand the potential of cannabis, particularly CBD. “[Retired athletes] are leaning on resources that aren’t sustainable, like opioids and alcohol and the traditional toolbox,” he said during an interview to be published with Kahner Global. “We give them an alternative with cannabis.”

Though cannabis continues to be banned throughout the sports world, some sports organizations are warming up to CBD. The World Anti-Doping Agency decided to remove it from its list of prohibited substances starting January 1, 2018. Meanwhile, in June 2018, the BIG3 League made headlines for becoming the first professional athletic league to openly embrace it.

Larger professional sports leagues are evidently softening their views on CBD and cannabis, as well. The National Hockey League does not suspend players who test positive for any kind of cannabinoid. Major League Baseball will only issue fines to those who test positive. The National Basketball League and the National Football League, meanwhile, will only suspend players who test positive after multiple violations.

Sports leagues are not the only ones becoming more tolerant of cannabis usage. A Gallup survey conducted in September 2018 found that 62 percent of Americans support legalizing cannabis — up from 31 percent in 2000.

These leagues are not only responding to the public’s changing views on cannabis; they are also considering the changing legal status of CBD. The Farm Bill that was signed into law in December made it legal to grow industrial hemp (defined as a cannabis plant containing less than 0.3 percent of THC) in more circumstances than in the past. This is a huge win for CBD, as industrial hemp is the plant from which the majority of CBD oil is extracted.

Though CBD is not yet legal in all 50 states, it has clearly been accepted as a part of mainstream culture. Although most professional leagues still prohibit athletes from using any form of cannabis product, usage of CBD among athletes is likely to continue to become more common. Thanks to its ability to treat many athletic ailments, CBD usage could soon be as common as a post-game ice bath.

About Orion Nutraceuticals Inc.
Orion Nutraceuticals is partners with Colombian based medical cannabis corporation FCM Global. FCM supplies pharmaceutical, nutritional, wellness, and cosmetic companies in legal markets worldwide with customized medical cannabis extracts, oils, and isolates at commercial scale. Medic-Oasis,Orion’s subsidiary, has submitted its application for anACMPR license and is currently under review with Health Canada. Build out is expected to begin in Q1 2019, with completion of the 31,000 square foot facility expected by Q3 2020.Orion Nutraceuticals Inc. aims to set a new standard in cannabis life science by producing and developing innovative products with key strategic partners in the industry. In conjunction with its professional sports strategic alliances, the company is poised to advance research and development in the plant science sector, deliver science-based products and services, and market CBD therapies to the mainstream with proprietary brands and products. Orion shares trade in Canada on the CSE under the symbol ORI.

Jonathan Fiteni, CEO
Orion Nutraceuticals Inc.